Trial Outcomes & Findings for Embolization in Splenic Trauma (NCT NCT03613454)

NCT ID: NCT03613454

Last Updated: 2021-08-11

Results Overview

The primary outcome of the study will be enrolling 50 participants in the study within 18 months of study initiation with adequate 30 day follow-up on all participants.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

48 participants

Primary outcome timeframe

Through study completion, an average of 1 year

Results posted on

2021-08-11

Participant Flow

Participant milestones

Participant milestones
Measure
Splenic Artery Embolization With Vascular Embolic Coils
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Overall Study
STARTED
24
24
Overall Study
COMPLETED
23
23
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Reasons for withdrawal
Measure
Splenic Artery Embolization With Vascular Embolic Coils
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Overall Study
Protocol Violation
0
1

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=24 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=24 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Total
n=48 Participants
Total of all reporting groups
Age, Continuous
39 years
n=24 Participants
34 years
n=24 Participants
38 years
n=48 Participants
Sex: Female, Male
Female
6 Participants
n=24 Participants
7 Participants
n=24 Participants
13 Participants
n=48 Participants
Sex: Female, Male
Male
18 Participants
n=24 Participants
17 Participants
n=24 Participants
35 Participants
n=48 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
24 participants
n=24 Participants
24 participants
n=24 Participants
48 participants
n=48 Participants

PRIMARY outcome

Timeframe: Through study completion, an average of 1 year

Population: Two participants dropped out due to protocol violation (invalid consent)

The primary outcome of the study will be enrolling 50 participants in the study within 18 months of study initiation with adequate 30 day follow-up on all participants.

Outcome measures

Outcome measures
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Number of Participants Who Were Enrolled Within 18 Months of Study Initiation
23 Participants
23 Participants

SECONDARY outcome

Timeframe: Through study completion, an average of 1 year

Population: Two participants dropped out due to protocol violation (invalid consent)

This outcome will be measured by the ability of the operator to deploy the required embolic with resultant stasis in the splenic artery. This will be compared between the two groups.

Outcome measures

Outcome measures
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Number of Participants With Embolization Success
22 Participants
20 Participants

SECONDARY outcome

Timeframe: During the embolization procedure, an average of 1 hour

Population: Two participants dropped out due to protocol violation (invalid consent)

This outcome will be measured by the number of intra-procedural complications and compared between the two groups

Outcome measures

Outcome measures
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Number of Participants With Immediate Complications
2 Participants
1 Participants

SECONDARY outcome

Timeframe: 30 days after procedure

Population: Two participants dropped out due to protocol violation (invalid consent)

This outcome will be measured by splenic salvage rate at 30 days and compared between groups. Splenic salvage was defined as the absence of splenectomy in the medical record or per patient report.

Outcome measures

Outcome measures
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Number of Participants With Splenic Salvage
22 Participants
23 Participants

SECONDARY outcome

Timeframe: During the embolization procedure, an average of 1 hour

Population: Two participants dropped out due to protocol violation (invalid consent)

The radiation exposure during the embolization procedure for each embolic will be measured and compared.

Outcome measures

Outcome measures
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Radiation Exposure
250 mGy
Interval 172.0 to 671.0
380 mGy
Interval 221.0 to 675.0

SECONDARY outcome

Timeframe: During the embolization procedure, an average of 1 hour

Population: Two participants dropped out due to protocol violation (invalid consent)

The amount of contrast used during the procedure will be measured for each group and compared.

Outcome measures

Outcome measures
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 Participants
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 Participants
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Contrast Volume
54 mL
Interval 41.0 to 60.0
60 mL
Interval 50.0 to 75.0

Adverse Events

Splenic Artery Embolization With Vascular Embolic Coils

Serious events: 1 serious events
Other events: 1 other events
Deaths: 1 deaths

Splenic Artery Embolization With Vascular Embolic Plugs

Serious events: 1 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Serious adverse events
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 participants at risk
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 participants at risk
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Surgical and medical procedures
Coil migration
4.3%
1/23 • Number of events 1 • Complications were recorded within 30 days from the procedure.
Two participants dropped out due to protocol violation (invalid consent).
0.00%
0/23 • Complications were recorded within 30 days from the procedure.
Two participants dropped out due to protocol violation (invalid consent).
Surgical and medical procedures
Vascular injury
0.00%
0/23 • Complications were recorded within 30 days from the procedure.
Two participants dropped out due to protocol violation (invalid consent).
4.3%
1/23 • Number of events 1 • Complications were recorded within 30 days from the procedure.
Two participants dropped out due to protocol violation (invalid consent).

Other adverse events

Other adverse events
Measure
Splenic Artery Embolization With Vascular Embolic Coils
n=23 participants at risk
Splenic artery embolization with vascular embolic coils: Splenic artery embolization with vascular embolic coils
Splenic Artery Embolization With Vascular Embolic Plugs
n=23 participants at risk
Splenic artery embolization with vascular embolic plugs: Splenic artery embolization with vascular embolic plugs
Surgical and medical procedures
Coil migration
4.3%
1/23 • Number of events 1 • Complications were recorded within 30 days from the procedure.
Two participants dropped out due to protocol violation (invalid consent).
0.00%
0/23 • Complications were recorded within 30 days from the procedure.
Two participants dropped out due to protocol violation (invalid consent).

Additional Information

Dr. AJ Gunn

University of Alabama at Birmingham

Phone: 205-975-4850

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place